- Home
- OUT vs DNLI Comparison
OUT vs DNLI Comparison
Compare OUT & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUT
- DNLI
- Stock Information
- Founded
- OUT 2013
- DNLI 2013
- Country
- OUT United States
- DNLI United States
- Employees
- OUT N/A
- DNLI N/A
- Industry
- OUT Real Estate Investment Trusts
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OUT Real Estate
- DNLI Health Care
- Exchange
- OUT Nasdaq
- DNLI Nasdaq
- Market Cap
- OUT 2.9B
- DNLI 3.3B
- IPO Year
- OUT N/A
- DNLI 2017
- Fundamental
- Price
- OUT $18.94
- DNLI $21.93
- Analyst Decision
- OUT Hold
- DNLI Strong Buy
- Analyst Count
- OUT 6
- DNLI 13
- Target Price
- OUT $19.00
- DNLI $38.91
- AVG Volume (30 Days)
- OUT 1.6M
- DNLI 1.1M
- Earning Date
- OUT 02-19-2025
- DNLI 02-25-2025
- Dividend Yield
- OUT 4.76%
- DNLI N/A
- EPS Growth
- OUT N/A
- DNLI N/A
- EPS
- OUT 1.41
- DNLI N/A
- Revenue
- OUT $1,838,900,000.00
- DNLI N/A
- Revenue This Year
- OUT N/A
- DNLI N/A
- Revenue Next Year
- OUT $1.95
- DNLI $651.24
- P/E Ratio
- OUT $13.40
- DNLI N/A
- Revenue Growth
- OUT 1.37
- DNLI 204.74
- 52 Week Low
- OUT $12.57
- DNLI $14.56
- 52 Week High
- OUT $19.98
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- OUT 59.01
- DNLI 51.28
- Support Level
- OUT $17.17
- DNLI $18.52
- Resistance Level
- OUT $18.29
- DNLI $22.37
- Average True Range (ATR)
- OUT 0.48
- DNLI 1.31
- MACD
- OUT 0.08
- DNLI 0.31
- Stochastic Oscillator
- OUT 83.48
- DNLI 88.57
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's major customers include entities within the retail, television, healthcare, and entertainment industries.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.